terlipressin has been researched along with Shock, Septic in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 59 (64.84) | 29.6817 |
2010's | 24 (26.37) | 24.3611 |
2020's | 8 (8.79) | 2.80 |
Authors | Studies |
---|---|
Allam, R; Awad, H; Ibrahim, M; Ismail, R; Shehata, B; Youssef, O | 1 |
Huang, L; Huang, Y; Li, Q; Liu, S; Meng, S; Shi, M; Wang, J; Xie, J; Xu, J; Xue, M | 1 |
Liang, D; Lin, L; Mao, F; Tang, Z; Xu, Y | 1 |
Duclos, G; Leone, M; Mathieu, C; Medam, S; Meresse, Z; Vincent, JL | 1 |
Chang, W; Huang, L; Liu, S; Qiu, H; Xia, F; Yang, Y; Zhang, S | 1 |
Du, X; Li, W; Pan, P; Wang, Y; Yu, X | 1 |
Chen, Q; Chen, Y; Huang, Z | 1 |
Castanon-Lopez, L; Oulego-Erroz, I; Rodriguez-Nunez, A; Terroba-Seara, S | 1 |
Chen, Z; Lu, Y; Yang, C; Zhou, P | 1 |
Arnemann, PH; Becker, K; Ertmer, C; Hessler, M; Kampmeier, TG; Morelli, A; Rehberg, SW; Seidel, LM | 1 |
Chen, J; Feng, Y; Gu, Q; Guan, XD; He, X; Huang, X; Kang, Y; Kou, Q; Li, K; Lin, A; Lin, J; Lin, Q; Liu, ZM; Qian, K; Shi, X; Song, Q; Sun, T; Tang, Z; Wang, C; Wang, X; Wu, B; Yuan, S; Zhao, L; Zhou, L | 1 |
Gordon, AC; Mårtensson, J | 1 |
Cantaloube, M; Duclos, G; Leone, M; Medam, S; Resseguier, N | 1 |
Chen, M; Chen, Q; Cheng, L; Han, S; Jiang, H; Lu, J; Yan, J | 1 |
Biban, P; Gaffuri, M | 1 |
Huang, Y; Qiu, H; Qiu, X; Xu, J; Yang, Y | 1 |
Chen, XM; Li, T; Liu, L; Xiao, X; Yue, W; Zhen, D; Zhu, Y | 1 |
Avni, T; Grossman, A; Lador, A; Leibovici, L; Lev, S; Paul, M | 1 |
Bhadoria, AS; Choudhury, A; Joshi, YK; Kedarisetty, CK; Kumar, G; Kumar, S; Maiwall, R; Saini, D; Sarin, SK; Sharma, MK; Vashishtha, C | 1 |
Coleman, N; Miller, A | 1 |
Ertmer, C; Morelli, A; Westphal, M | 1 |
Leone, M; Martin, C | 2 |
Singer, M | 1 |
Broelsch, CE; Canbay, A; Gerken, G; Saner, FH | 1 |
Andrea, M; Ertmer, C; Morelli, A; Rehberg, S; Westphal, M | 1 |
Ertmer, C; Köhler, G; Lange, M; Moll, K; Morelli, A; Rehberg, S; Schlack, K; Spiegel, HU; Su, F; Van Aken, H; Vincent, JL; Westphal, M | 1 |
Meyer, S | 1 |
Lopez-Herce, J; Martínez, V; Rodriguez-Nunez, A | 1 |
Bachetoni, A; Cecchini, V; D'Alessandro, M; Ertmer, C; Lange, M; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Van Aken, H; Westphal, M | 1 |
Ertmer, C; Morelli, A; Pietropaoli, P; Westphal, M | 1 |
Leone, M | 1 |
Asfar, P; Calès, P; Oberti, F; Radermacher, P | 1 |
Carneiro, AH; Póvoa, P | 1 |
Al-Naeeb, Y; Aravinthan, A; Richardson, P | 1 |
Erkek, N; Hizli, S; Karacan, CD; Senel, S | 1 |
Gaboli, M; Gil-Antón, J; López-Herce, J; Milano, G; Oulego-Erroz, I; Pérez-Caballero, C; Rodríguez-Núñez, A | 1 |
Kampmeier, TG; Lange, M; Rehberg, S; Westphal, M | 1 |
Catarzi, S; Daniotti, M; Filippi, L; Fiorini, P; Gozzini, E; Pagliai, F | 1 |
Gortner, L; Gottschling, S; McGuire, W; Meyer, S; Mohammed Shamdeen, G | 1 |
Maybauer, DM; Maybauer, MO | 1 |
Di Russo, A; Donati, A; Ertmer, C; Morelli, A; Orecchioni, A; Pelaia, P; Pietropaoli, P; Rehberg, S; Westphal, M | 1 |
Botticelli, L; D'Egidio, A; Di Russo, A; Donati, A; Ertmer, C; Kampmeier, T; Landoni, G; Lombrano, MR; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Valentini, A; Westphal, M; Zangrillo, A | 1 |
Bailey, M; Bellomo, R; Calzavacca, P; Ishikawa, K; May, CN; Wan, L | 1 |
Doubek, J; Dudra, J; Kantorová, I; Radvan, M; Radvanova, J; Scheer, P; Svoboda, P | 1 |
Hua, F; Wang, X; Zhu, L | 1 |
Barrière, E; Bernuau, D; Chauvelot-Moachon, L; Dargère, D; Guimont, MC; Lardeux, B; Lebrec, D; Moreau, R; Poirel, O; Tazi, KA; Urbanowicz, W | 1 |
Bone, HG; Sielenkämper, AW; Van Aken, H; Westphal, M | 1 |
Alquier, P; Asfar, P; Calès, P; Croquet, V; Douay, O; Gallois, Y; Moal, F; Oberti, F; Pierrot, M; Saumet, JL; Veal, N | 1 |
Landry, DW; Oliver, JA | 1 |
Ball, C; Bone, HG; Borgulya, R; Sielenkämper, AW; Stubbe, H; Van Aken, H; Westphal, M | 1 |
De Keulenaer, BL; Stephens, DP | 1 |
Asfar, P | 1 |
Bénard, P; Daccache, G; Fellahi, JL; Gérard, JL; Mourgeon, E | 1 |
Coluzzi, F; Conti, G; Cortese, G; De Gaetano, A; Morelli, A; Orecchioni, A; Pelaia, P; Pietropaoli, P; Rocco, M; Vernaglione, E | 1 |
Fernández-Sanmartín, M; González-Alonso, N; Martinón-Sánchez, JM; Martinón-Torres, F; Rodríguez-Núñez, A | 1 |
Booth, RA; Peters, MJ; Petros, AJ | 1 |
Adam, M; Barzilay, Z; Leibovitch, L; Matok, I; Paret, G; Rubinshtein, M; Vardi, A | 1 |
Bone, HG; Ertmer, C; Van Aken, H; Westphal, M | 2 |
Berg, RA | 1 |
Factor, P; Mutlu, GM | 1 |
Allen, EK; Bradley, PG; Menon, DK | 1 |
Lubanda, H; Novák, F; Onderková, R; Zák, A | 1 |
Jørgensen, VL; Perner, A; Waldau, T | 1 |
Lebrec, D | 1 |
Albanèse, J; Chaabane, W; Delmas, A; Garnier, F; Leone, M; Martin, C | 1 |
Albanèse, J; Delmas, A; Leone, M; Martin, C; Rousseau, S | 1 |
Adam, M; Barzilay, Z; Efrati, O; Leibovitch, L; Matok, I; Paret, G; Rubinshtein, M; Vard, A; Vishne, T | 1 |
Boerma, EC; Ince, C; van der Voort, PH | 1 |
Albanèse, J; Delmas, A; Leone, M; Martin, C | 1 |
Bracco, D; Dubois, MJ | 1 |
Brandstrup, KB; Fernández, C; López-Herce, J; Rodríguez-Núñez, A; Zeballos, G | 1 |
Gil-Antón, J; Hernández, A; López-Herce, J; Rey, C; Rodríguez-Núñez, A | 1 |
Lebrec, D; Moreau, R | 1 |
Borer, A; Gurman, GM; Kesslin, J; Klein, M; Koyfman, L; Weksler, N | 1 |
Jennings, HR; Pesaturo, AB; Voils, SA | 1 |
Dunwoodie, E; Jowett, S | 1 |
Ertmer, C; Lange, M; Morelli, A; Westphal, M | 1 |
Zuberi, BF | 1 |
David, M; Di Marco, JN; Lagier, P; Martin, C; Michel, F; Nicaise, C; Thomachot, L; Vialet, R | 1 |
Huber, W; Reindl, W; Schmid, RM; Umgelter, A | 1 |
Ertmer, C; Lange, M; Westphal, M | 1 |
Alhan, E; Celik, U; Sertdemir, Y; Yapicioglu, H; Yildizdas, D | 1 |
Kalambokis, G; Korantzopoulos, P; Nikas, SA; Theodorou, A; Tsianos, EV | 1 |
Filippi, L; Fiorini, P; Poggi, C; Serafini, L | 1 |
Dünser, M; Ertmer, C; Lange, M; Morelli, A; Pietropaoli, P; Rehberg, S; Van Aken, H; Westphal, M | 1 |
Arroyo, V; Díaz, F; Fábrega, E; Ginès, P; Guevara, M; Martín-Llahí, M; Monescillo, A; Pépin, MN; Rodés, J; Soriano, G; Terra, C; Torre, A | 1 |
Appenrodt, B; Blei, A; Boyer, T; Garcia-Tsao, G; Gülberg, V; Regenstein, F; Rossaro, L; Sanyal, AJ; Sigal, S; Teuber, P | 1 |
Groszmann, RJ; Lim, JK | 1 |
Clapp, L; O'Brien, A; Singer, M | 1 |
26 review(s) available for terlipressin and Shock, Septic
Article | Year |
---|---|
TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW.
Topics: Adult; Combined Modality Therapy; Humans; Lypressin; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2023 |
Vasopressors to treat refractory septic shock.
Topics: Humans; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2020 |
Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis.
Topics: Adult; Humans; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2020 |
[Effect of terlipressin on prognosis of adult septic shock patients: a Meta-analysis].
Topics: Adult; Humans; Norepinephrine; Prognosis; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2020 |
Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials.
Topics: Catecholamines; Dopamine; Humans; Mortality; Norepinephrine; Odds Ratio; Randomized Controlled Trials as Topic; Shock, Septic; Terlipressin; Vasopressins | 2019 |
Vasopressin and terlipressin in neonates and children with refractory septic shock.
Topics: Child; Humans; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2013 |
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Topics: Epinephrine; Hemodynamics; Humans; Lypressin; Norepinephrine; Phenylephrine; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2015 |
"Terlipressin in the treatment of septic shock: the earlier the better"?
Topics: Animals; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
Topics: Animals; Catecholamines; Drug Resistance; Humans; Infant; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Arginine vasopressin vs. terlipressin in the treatment of shock states.
Topics: Animals; Arginine Vasopressin; Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Shock; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2007 |
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
Topics: Animals; Cardiac Output; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
The effects of vasopressin and its analogues on the liver and its disorders in the critically ill.
Topics: Critical Care; Critical Illness; Hemodynamics; Hepatorenal Syndrome; Humans; Intensive Care Units; Liver; Liver Cirrhosis; Lypressin; Risk Factors; Shock, Septic; Terlipressin; Varicose Veins; Vasoconstrictor Agents; Vasopressins | 2010 |
Adrenergic support in septic shock: a critical review.
Topics: Adrenergic Agents; Algorithms; Blood Flow Velocity; Blood Pressure; Cardiotonic Agents; Decision Trees; Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Humans; Lypressin; Monitoring, Physiologic; Norepinephrine; Patient Selection; Practice Guidelines as Topic; Resuscitation; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2010 |
Relative adrenal insufficiency in a patient with liver disease.
Topics: Adrenal Insufficiency; Cefotaxime; Female; Humans; Hydrocortisone; Liver Cirrhosis, Alcoholic; Lypressin; Middle Aged; Multiple Organ Failure; Norepinephrine; Severity of Illness Index; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Vasopressin in sepsis and septic shock.
Topics: Adrenal Cortex Hormones; Animals; Arginine Vasopressin; Catecholamines; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Humans; Hypotension; Ischemia; Lypressin; Molecular Structure; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sepsis; Shock, Septic; Terlipressin; Vasoconstriction; Vasoconstrictor Agents | 2010 |
The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.
Topics: Adolescent; Arginine Vasopressin; Cardiac Output, Low; Cardiopulmonary Resuscitation; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Arrest; Hemodynamics; Hospital Mortality; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lypressin; Male; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Shock, Septic; Survival Rate; Terlipressin; Young Adult | 2011 |
Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?
Topics: Animals; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Lypressin; Oxygen Consumption; Safety; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2003 |
Role of vasopressin in the management of septic shock.
Topics: Amino Acid Sequence; Blood Circulation; Blood Pressure; Dose-Response Relationship, Drug; Humans; Lypressin; Models, Biological; Osmolar Concentration; Pulmonary Circulation; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2004 |
[Vasopressin and its analogues in the therapy of shock].
Topics: Animals; Humans; Lypressin; Shock; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2004 |
Review article: future indications for terlipressin therapy.
Topics: Animals; Cardiopulmonary Resuscitation; Hepatorenal Syndrome; Humans; Lypressin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paracentesis; Rats; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Clinical review: Vasopressin and terlipressin in septic shock patients.
Topics: Adult; Animals; Antidiuretic Agents; Cardiac Output; Child; Diuresis; Drug Therapy, Combination; Epinephrine; Humans; Infusions, Parenteral; Intensive Care Units; Kidney; Lypressin; Multiple Organ Failure; Randomized Controlled Trials as Topic; Sheep; Shock, Septic; Swine; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2005 |
The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Topics: Adrenergic alpha-Agonists; Cardiovascular Diseases; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Paracentesis; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2006 |
Rescue therapy in septic shock--is terlipressin the last frontier?
Topics: Animals; Humans; Lypressin; Shock, Septic; Terlipressin | 2006 |
Terlipressin: vasopressin analog and novel drug for septic shock.
Topics: Animals; Humans; Lypressin; Receptors, Vasopressin; Shock, Septic; Terlipressin; Vasopressins | 2006 |
Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
Topics: Arginine Vasopressin; Humans; Infusions, Intravenous; Lypressin; Metabolic Clearance Rate; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
18 trial(s) available for terlipressin and Shock, Septic
Article | Year |
---|---|
Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: A randomized controlled trial.
Topics: Hemodynamics; Humans; Infant; Infant, Newborn; Infant, Premature; Methylene Blue; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2022 |
Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study.
Topics: Humans; Norepinephrine; Pilot Projects; Renal Circulation; Shock, Septic; Terlipressin; Treatment Outcome | 2022 |
[Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial].
Topics: Berlin; Hemodynamics; Humans; Lypressin; Norepinephrine; Prospective Studies; Respiratory Distress Syndrome; Shock, Septic; Single-Blind Method; Terlipressin | 2017 |
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
Topics: Adult; Aged; China; Critical Care; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Norepinephrine; Shock, Septic; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2018 |
A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.
Topics: Adult; Female; Hemodynamics; Humans; India; Kaplan-Meier Estimate; Lactic Acid; Liver Cirrhosis; Logistic Models; Lypressin; Male; Microcirculation; Middle Aged; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2017 |
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Topics: Acid-Base Equilibrium; Aged; Dobutamine; Female; Hemodynamics; Homeostasis; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Pilot Projects; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2009 |
Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
Topics: Adrenergic alpha-Agonists; Aged; Arginine Vasopressin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Microcirculation; Middle Aged; Mouth Floor; Norepinephrine; Prospective Studies; Receptors, Vasopressin; Shock, Septic; Terlipressin | 2011 |
Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2012 |
Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock.
Topics: Blood Pressure; Dopamine; Dopamine Agents; Female; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Prospective Studies; Respiratory Distress Syndrome; Shock, Septic; Terlipressin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2013 |
Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
Topics: Aged; Catecholamines; Catheterization, Swan-Ganz; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Hemodynamics; Humans; Infant, Newborn; Intensive Care Units; Laser-Doppler Flowmetry; Lypressin; Male; Manometry; Middle Aged; Prospective Studies; Pulmonary Artery; Shock, Septic; Terlipressin; Urination; Vasoconstrictor Agents | 2004 |
Terlipressin for catecholamine-resistant septic shock in children.
Topics: Catecholamines; Child; Child, Preschool; Drug Resistance; Humans; Hypotension; Infant; Infusions, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin in catecholamine-resistant septic shock patients.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Platelets; Drug Resistance; Epinephrine; Female; France; Heart Rate; Hospital Mortality; Humans; Hypotension; Lactic Acid; Lypressin; Male; Middle Aged; Multiple Organ Failure; Norepinephrine; Oxygen Consumption; Prospective Studies; Shock, Septic; Terlipressin; Urodynamics; Vasoconstrictor Agents | 2004 |
Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Lactates; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Oxygen Consumption; Prospective Studies; Pulmonary Circulation; Shock, Septic; Stroke Volume; Terlipressin; Vascular Resistance; Vasoconstrictor Agents | 2005 |
Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.
Topics: Adolescent; Blood Pressure; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Rate; Humans; Hypotension; Intensive Care Units, Pediatric; Length of Stay; Lypressin; Male; Oxygen; Prospective Studies; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Topics: Acid-Base Equilibrium; Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Critical Care; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Oxygen Consumption; Partial Pressure; Pilot Projects; Prospective Studies; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Topics: Adolescent; Adult; Aged; Albumins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Shock, Septic; Survival Rate; Terlipressin; Time Factors; Treatment Outcome; United States; Vasoconstrictor Agents | 2008 |
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Germany; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney Function Tests; Lypressin; Male; Middle Aged; Prospective Studies; Russia; Severity of Illness Index; Shock, Septic; Survival Rate; Terlipressin; Treatment Outcome; United States; Vasoconstrictor Agents | 2008 |
Terlipressin for norepinephrine-resistant septic shock.
Topics: Adult; Aged; APACHE; Half-Life; Hemodynamics; Humans; Lypressin; Middle Aged; Norepinephrine; Shock, Septic; Survival Rate; Terlipressin; Vasoconstrictor Agents | 2002 |
47 other study(ies) available for terlipressin and Shock, Septic
Article | Year |
---|---|
Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report.
Topics: Adult; Child; Humans; Hypotension; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2020 |
Rescue Treatment with Terlipressin for Persistent Pulmonary Hypertension and Refractory Shock in a Preterm Infant.
Topics: Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Shock; Shock, Septic; Terlipressin | 2020 |
Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock.
Topics: Animals; Catecholamines; Hemodynamics; Kidney; Norepinephrine; Peritoneal Lavage; Sheep, Domestic; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2018 |
Terlipressin or norepinephrine, or both in septic shock?
Topics: Hemodynamics; Humans; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2018 |
Preliminary results of synergy between norepinephrine and terlipressin during septic shock.
Topics: Hemodynamics; Humans; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2019 |
Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock.
Topics: Acid-Base Equilibrium; Animals; Drug Evaluation, Preclinical; Hemodynamics; Lypressin; Male; Microcirculation; Norepinephrine; Oxygen; Random Allocation; Rats, Wistar; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2014 |
Beneficial and side effects of arginine vasopressin and terlipressin for septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Calcium; Dose-Response Relationship, Drug; Female; Lypressin; Male; Norepinephrine; Rabbits; Rats; Rats, Sprague-Dawley; Sex Characteristics; Shock, Septic; Terlipressin | 2015 |
Dobutamine and terlipressin in patients with septic shock.
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Terlipressin--more than just a prodrug of lysine vasopressin?
Topics: Animals; Humans; Lypressin; Prodrugs; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
Topics: Animals; Arginine Vasopressin; Drug Therapy, Combination; Female; Hemodynamics; Lypressin; Random Allocation; Sheep; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Comment: Terlipressin for children with extremely low cardiac output after open heart surgery.
Topics: Arginine Vasopressin; Cardiac Output, Low; Child; Hemodynamics; Humans; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin continuous infusion: please mind the solvent!
Topics: Drug Stability; Glucose; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Lypressin; Shock, Septic; Sodium Chloride; Solutions; Solvents; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin or europressin?
Topics: Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin saved the life of a child with severe nonvariceal upper gastrointestinal bleeding.
Topics: Duodenal Diseases; Emergency Service, Hospital; Gastrointestinal Hemorrhage; Humans; Infant; Lypressin; Male; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock.
Topics: Adolescent; Blood Pressure; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Hemodynamics; Hospitals, University; Humans; Hypotension; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Pediatric; Ischemia; Lypressin; Male; Prospective Studies; Shock, Septic; Spain; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2010 |
Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants.
Topics: Catecholamines; Female; Humans; Hypotension; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Lypressin; Male; Medical Audit; Retrospective Studies; Shock, Septic; Terlipressin; Ultrasonography; Vasoconstrictor Agents | 2011 |
Vasopressin analogues and V1a receptor agonists in septic shock.
Topics: Arginine Vasopressin; Catecholamines; Clinical Trials as Topic; Humans; Lypressin; Microcirculation; Perfusion; Receptors, Vasopressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2011 |
Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Hospitals, University; Humans; Intensive Care Units; Lypressin; Male; Microcirculation; Middle Aged; Mouth Floor; Prospective Studies; Shock, Septic; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Young Adult | 2011 |
The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.
Topics: Animals; Escherichia coli; Escherichia coli Infections; Female; Hemodynamics; Kidney; Lypressin; Regional Blood Flow; Sheep; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2012 |
Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
Topics: Alanine Transaminase; Animals; Aorta, Thoracic; Blood Pressure; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hypotension; Lipopolysaccharides; Liver Cirrhosis, Biliary; Lypressin; Lysine; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Shock, Septic; Terlipressin; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2002 |
Terlipressin for haemodynamic support in septic patients: a double-edged sword?
Topics: Animals; Hemodynamics; Humans; Intestinal Mucosa; Ischemia; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2002 |
Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats.
Topics: Animals; Hemodynamics; Lypressin; Male; Microcirculation; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Splanchnic Circulation; Statistics, Nonparametric; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2003 |
Patient with a sudden drop in blood pressure.
Topics: Animals; Fluid Therapy; Humans; Hypotension; Lypressin; Rats; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2003 |
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.
Topics: Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endotoxemia; Female; Hemodynamics; Infusions, Intravenous; Lypressin; Oxygen Consumption; Prospective Studies; Pulmonary Circulation; Respiratory Transport; Sheep; Shock, Septic; Terlipressin; Typhoid Fever; Vasoconstrictor Agents | 2003 |
Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar.
Topics: Animals; Gastrointestinal Hemorrhage; Humans; Hypotension; Ischemia; Lypressin; Rats; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2003 |
[Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
Topics: Adrenergic beta-Agonists; Aged; Catecholamines; Dobutamine; Drug Resistance; Female; Hemodynamics; Humans; Infusions, Intravenous; Lypressin; Male; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2003 |
Terlipressin bolus induces systemic vasoconstriction in septic shock.
Topics: Child; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Lypressin; Male; Norepinephrine; Shock, Septic; Terlipressin; Vascular Resistance; Vasoconstrictor Agents | 2004 |
Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock.
Topics: Blood Pressure; Catecholamines; Humans; Hypotension; Infant, Newborn; Injections, Intravenous; Klebsiella Infections; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin in patients with septic shock: friend or foe?
Topics: Humans; Lypressin; Oxygen Consumption; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
A long-acting vasopressin analog for septic shock: brilliant idea or dangerous folly?
Topics: Child; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin for cerebral perfusion pressure support in a patient with septic shock.
Topics: Cerebrovascular Circulation; Critical Care; Female; Humans; Intracranial Aneurysm; Lypressin; Middle Aged; Postoperative Complications; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin increased the concentration of L-lactate in the rectal lumen in a patient with septic shock.
Topics: Aged; Cardiac Output; Dialysis; Hemodynamics; Humans; Lactic Acid; Lypressin; Male; Norepinephrine; Rectum; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin as rescue therapy for intractable hypotension due to septic shock in children.
Topics: Adolescent; Antihypertensive Agents; Blood Pressure; Catecholamines; Child; Child, Preschool; Creatinine; Epinephrine; Female; Heart Rate; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Oxygen; Prognosis; Shock, Septic; Terlipressin; Time Factors | 2005 |
Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock.
Topics: Acid-Base Equilibrium; Aged, 80 and over; Blood Pressure; Catecholamines; Drug Resistance; Fatal Outcome; Female; Hemodynamics; Humans; Lypressin; Meningitis, Meningococcal; Microcirculation; Mouth Floor; Regional Blood Flow; Respiration, Artificial; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2005 |
Hemodynamic support in septic shock: is restoring a normal blood pressure the right target?
Topics: Blood Pressure; Humans; Lypressin; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2005 |
Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock.
Topics: Blood Pressure; Catecholamines; Fatal Outcome; Female; Humans; Hypotension; Infant; Infusions, Intravenous; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2006 |
Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Meningitis, Meningococcal; Prospective Studies; Shock, Septic; Staphylococcal Infections; Terlipressin | 2006 |
Terlipressin for haemodynamic support in septic shock: less may be more.
Topics: Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2006 |
Terlipressin facilitates transport of septic patients treated with norepinephrine.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Retrospective Studies; Shock, Septic; Terlipressin; Transportation of Patients; Vasoconstrictor Agents | 2006 |
Terlipressin causing a hyponatraemic seizure.
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hyponatremia; Ligation; Lypressin; Middle Aged; Seizures; Shock, Septic; Sodium; Terlipressin; Vasoconstrictor Agents | 2007 |
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?
Topics: Adult; Aged; Critical Care; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2007 |
Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
Topics: Blood Pressure; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock.
Topics: Child, Preschool; Female; Humans; Infusions, Parenteral; Lypressin; Meningococcal Infections; Neisseria meningitidis, Serogroup B; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2007 |
Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver.
Topics: Adult; Aged; Critical Care; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment.
Topics: Adult; Antihypertensive Agents; Follow-Up Studies; Humans; Hypertension, Portal; Hypertension, Pulmonary; Injections, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Time Factors | 2008 |
Terlipressin as rescue treatment of refractory shock in a neonate.
Topics: Abdominal Neoplasms; Fatal Outcome; Humans; Infant, Newborn; Lypressin; Male; Neuroblastoma; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2008 |
Vasoconstrictor therapy for the hepatorenal syndrome.
Topics: Dose-Response Relationship, Drug; Hepatorenal Syndrome; Humans; Injections, Intravenous; Lypressin; Severity of Illness Index; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |